Some of the questions we’ll discuss include:
The incidence of fungal infections is rising in immunocompromised people, and the morbidity and mortality of these infections are high. Recent threats include multi-drug resistant Candida auris, however antifungal resistance is rising in other species as well, such as Aspergillus fumigatus. But have advances in diagnostic testing kept up with the accelerating threats of fungal infections?
- What would you select as a disease specific gap?
- methodological gaps – what’s the need and how could it be addressed?
- What’s next for the Fungal Diagnostics Laboratories Consortium?
Guests: Dr. Esther Babady, Dr. Sean Zhang, Dr. Shawn LockhartVisit jcm.asm.org to read articles and/or submit a manuscript.